Study the early death reason in patients with acute promyelocytic leukemia (APL).
探讨急性早幼粒细胞白血病（APL）患者早期死亡原因。
Objective:To study the early death reason in patients with acute promyelocytic leukemia (APL).
目的：探讨急性早幼粒细胞白血病（APL）患者早期死亡原因。
Objective To study the morphologic and cytogenetic change in acute promyelocytic leukemia (APL) patients during the tetra arsenic tetra sulfide (TATS) treatment and the mechanism of TATS.
目的观察四硫化四砷（TATS）治疗初治和复发急性早幼粒细胞白血病（APL）过程中细胞形态学及细胞遗传学变化，探讨其作用机制。
Objective To further understand the possible mechanism of realgar in the treatment of acute promyelocytic leukemia (APL).
目的了解雄黄治疗急性早幼粒细胞白血病（APL）的机制。
Objective To investigate the immunophenoytpe of acute promyelocytic leukemia(APL) and its clinical significance.
目的分析急性早幼粒细胞白血病（APL）免疫表型特点及其临床意义。
Objective: To study the possible mechanism of red orpiment, which is main component of composite indigo naturalis tablets, in the treatment of acute promyelocytic leukemia(APL).
目的：研究复方青黛片的主要成分雄黄治疗急性早幼粒细胞白血病（APL）的机制。
Objective:To illustrate mechanisms of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia(APL).
目的：阐明氧化砷治疗急性早幼粒细胞白血病（APL）的机制。
Patients with certain subtypes of AML, such as acute promyelocytic leukemia (APL) have a higher chance of cure.
急性髓细胞白血病的分型也会影响其治愈率，如急性早幼粒细胞白血病的治愈率就相对较高。
Patients with certain subtypes of AML, such as acute promyelocytic leukemia (APL) have a higher chance of cure.
急性髓细胞白血病的分型也会影响其治愈率，如急性早幼粒细胞白血病的治愈率就相对较高。
应用推荐